Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer
First, we discuss the latest twists following the…
July 8, 202131m 5s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
First, we discuss the latest twists following the FDA's widely condemned decision to approve Aduhelm, Biogen's treatment for Alzheimer's disease. Then, our STAT colleague Helen Branswell joins us to talk about whether viral variants are going to stymie the U.S.'s summer reopening. Finally, STAT's Mario Aguilar calls in to break down the record-setting sums going into digital health companies in 2021.